Oct 08, 2008 -
In This Report
- Highlights
- Introduction
- Blemishes
- Risk Factors
- Prevention
- Treatment
- Resurfacing Treatments
- Implant Procedures
- Plastic Surgery
- Resources
- References
HEALTH GUIDE REFERENCE FROM A.D.A.M
Highlights
Smoking and Skin Damage
- The skin of smokers ages more rapidly than the skin of non-smokers, even in areas of the body not exposed to sunlight, according to a 2007 study. Women in the study who smoked also had much lower levels of vitamin E secretions in their skin. Vitamin E may protect the skin from sun damage.
- There may be an association between smoking and higher frequency of a type of acne (noninflammatory acne) in adult women, according to a European study.
Antioxidants and Your Skin
- A study in the Journal of Nutrition found that a combination of antioxidants and trace elements supplementation raises the risk of skin cancer in women, but not in men.
Ultraviolet Radiation
- Overall, exposure to ultraviolet radiation from sunlight (radiation referred to as UVA or UVB) accounts for about 90% of the symptoms of premature skin aging.
- UVB primarily affects the outer skin layers.
- 0 Comments
Oct 08, 2008 -
In This Report
- Highlights
- Introduction
- Melanoma
- Nonmelanoma Skin Cancer
- Precancerous Skin Condition...
- Causes
- Risk Factors
- Prevention
- Screening
- Diagnosis
- Staging
- Treatment for Melanoma
- Treatment for Nonmelanoma S...
- Prognosis
- Resources
- References
HEALTH GUIDE REFERENCE FROM A.D.A.M
Highlights
Risk factors
According to a report in the Archives of Dermatology, marathon runners are more likely than the general population to develop skin changes that increase the risk for melanoma.
Prevention
A study published in The Lancet indicates that the best ways to avoid sun damage are to reduce the time you spend in the sun and to wear a hat and clothing to protect as much of your skin as possible. Fabrics that are thick and tightly woven offer the best protection.
- 0 Comments
Oct 08, 2008 -
In This Report
- Highlights
- Introduction
- Risk Factors
- Causes
- Prognosis
- Diagnosis
- Treatment
- Medications
- Other Treatments
- Therapy and Lifestyle Chang...
- Resources
- References
HEALTH GUIDE REFERENCE FROM A.D.A.M
Highlights
Drug Approval
In 2007, the FDA approved risperidone (Risperdal) for short-term treatment of manic or mixed episodes of bipolar I disorder in children ages 10 - 17. Risperidone (an atypical antipsychotic) and lithium (a mood stabilizer) are the two drugs currently approved for treating pediatric patients with bipolar disorder.
Drug Warnings
- Olanzapine (Zyprexa, Symbex) causes a greater risk for high blood sugar than other atypical antipsychotics, according to updated information added to the drug’s warning label.
- 1 Comment
Oct 08, 2008 -
In This Report
- Highlights
- Introduction
- Causes
- Risk Factors
- Complications of Depression...
- Diagnosis
- Treatment
- Antidepressants and Drug Tr...
- Psychotherapy
- Other Treatments
- Lifestyle Changes
- Resources
- References
HEALTH GUIDE REFERENCE FROM A.D.A.M
Highlights
Drug Approval
In 2007, the Food and Drug Administration (FDA) approved the atypical antipsychotic drug aripiprazole (Abilify) for treatment of major depression in adults. Aripiprazole is used for treatment of schizophrenia and bipolar disorder. For depression, it is used in combination with antidepressant drug therapy.
- 5 Comments
Oct 08, 2008 -
In This Report
- Highlights
- Introduction
- Causes
- Symptoms
- Risk Factors
- Prognosis
- Diagnosis
- Treatment
- Other Treatments
- Decongestants
- Antihistamines
- Corticosteroids
- Immunotherapy
- Prevention
- Resources
- References
HEALTH GUIDE REFERENCE FROM A.D.A.M
Highlights
Drug Approval
Ciclesonide (Omanaris), a corticosteroid nasal spray, has been approved for treatment of seasonal and perennial allergic rhinitis (hay fever) in adults and children age 12 years and older.
FDA Drug Warnings
- The antihistamine promethazine (Phenergan) should not be given to children younger than age 2 because it may cause serious breathing problems.
- Omalizumab (Xolair) may cause a life-threatening allergic reaction (anaphylaxis). This drug is used to treat allergy-related asthma, but is also being investigated as an allergy treatment.
Cough and Cold Medicines for Children
In 2007, the FDA began reviewing the safety and effectiveness of cough and cold medicines for children.
- 0 Comments
Oct 08, 2008 -
In This Report
- Highlights
- Introduction
- Causes
- Prognosis
- Risk Factors
- Symptoms
- Diagnosis
- Treatment
- Quick-Relief Medications...
- Long-Term Relief Medication...
- Other Treatments
- Managing Asthma
- Resources
- References
HEALTH GUIDE REFERENCE FROM A.D.A.M
Highlights
Drug Warning
In 2007, the FDA requested the manufacturers of omalizumab (Xolair) to include a “boxed warning” emphasizing that this drug may cause a severe and life-threatening allergic reaction (anaphylaxis). Health care providers need to carefully observe patients for 2 hours after they receive an omalizumab injection. However, because an allergic reaction can occur up to 24 hours after the injection, patients need to know the signs and symptoms of anaphylaxis and how to self-administer emergency treatment.
- 0 Comments
Oct 08, 2008 -
In This Report
- Highlights
- Introduction
- Symptoms
- Causes
- Prognosis
- Risk Factors
- Diagnosis
- Treatment
- Quick-Relief Medications...
- Long-Term Relief Medication...
- Other Treatments
- Managing Asthma
- Resources
- References
HEALTH GUIDE REFERENCE FROM A.D.A.M
Highlights
Drug Warning
In 2007, the FDA requested the manufacturers of omalizumab (Xolair) to include a “boxed warning” emphasizing that this drug may cause a severe and life-threatening allergic reaction (anaphylaxis). Omalizumab is approved for patients who have moderate-to-severe asthma related to allergies and whose symptoms are not controlled by inhaled corticosteroids. It is given by injection in a doctor’s office every 2 - 4 weeks.
- 0 Comments
Oct 08, 2008 -
In This Report
- Highlights
- Introduction
- Diphtheria, Tetanus, and Pe...
- Measles, Mumps, and Rubella...
- Varicella-Zoster Virus (Chi...
- Varicella-Zoster Virus (Shi...
- Hepatitis A
- Hepatitis B
- Pneumococcal Pneumonia
- Poliomyelitis
- Viral Influenza
- Haemophilus Influenzae Type...
- Human Papillomavirus (HPV)...
- Rotavirus
- Smallpox
- Other Vaccinations
- Resources
- References
HEALTH GUIDE REFERENCE FROM A.D.A.M
Highlights
Vaccines
- The Centers for Disease Control and Prevention now recommends that children receive 2 doses of the varicella-zoster (Chickenpox) vaccine: the initial vaccine between ages 12 - 15 months, and a booster between 4 - 6 years. Children aged 12 and older and adults who have not had the vaccine should receive 2 doses. Immunization guidelines were changed following research that indicated the effectiveness of the vaccine declines over time.
- 0 Comments
Oct 08, 2008 -
In This Report
- Highlights
- Introduction
- Causes
- Risk Factors
- Symptoms
- Prognosis
- Diagnosis
- Prevention
- Treatment
- Home Remedies
- Medications
- Surgery
- Resources
- References
HEALTH GUIDE REFERENCE FROM A.D.A.M
Highlights
Ear Infections
Middle ear (otitis media) infections are very common in young children. They include:
- Acute otitis media (AOM) is an inflammation caused by bacteria that travel to the middle ear from fluid trapped in the Eustachian tube. Children with AOM exhibit signs of an ear infection including pain, fever, and tugging at the ear.
- Otitis media with effusion (OME) refers to fluid that accumulates in the middle ear without obvious signs of infection.
- 0 Comments
Oct 08, 2008 -
In This Report
- Highlights
- Introduction
- Symptoms
- Risk Factors
- Complications
- Diseases with Similar Sympt...
- Diagnosis
- Treatment
- Prevention
- Human Granulocytic Anaplasm...
- Babesiosis
- Resources
- References
HEALTH GUIDE REFERENCE FROM A.D.A.M
Highlights
Lyme Disease Rates Double in Past 15 Years
The annual number of people newly infected with Lyme disease has doubled from around 10,000 cases per year in the early 1990s to about 20,000 cases per year now. Improved diagnosis and reporting probably contribute to this increase. In the United States, Massachusetts, New Jersey, and Pennsylvania have reported the highest number of Lyme disease cases in recent years.
- 0 Comments